Feasibility of a Federated Network Analysis Using Real-World Data Mapped to OMOP Common Data Model to Estimate Healthcare Resource Utilisation and Costs of Imminent Subsequent Fracture
Fabiano G. et al, (2024), Pharmacoepidemiology and drug safety, 33, 391 - 391
Large Scale Propensity Score Matching With Time-Stratification in Older Women With or Without Fractures in the UK
Chen X. et al, (2024), Pharmacoepidemiology and drug safety, 33, 573 - 573
Prescription Sequence Symmetry Analysis to Identify Prescription Cascades for Dementia Drug Treatments in the United Kingdom
Raventos B. et al, (2024), Pharmacoepidemiology and drug safety, 33, 399 - 400
Primary Care Resource Utilisation and Costs of Fragility Fractures in Postmenopausal Women in the UK Using CPRD Data Mapped to OMOP Common Data Model
Fabiano G. et al, (2024), Pharmacoepidemiology and drug safety, 33, 400 - 401
Using Prescription Symmetry Sequence Analysis in the Context of Antiparkinsonian Treatments in the United Kingdom
Chen X. et al, (2024), Pharmacoepidemiology and drug safety, 33, 27 - 27
Incidence and prevalence of Parkinson's disease and utilization of antiparkinson treatments: A population-based cohort study
Chen X. et al, (2023), Pharmacoepidemiology and drug safety, 32, 465 - 465